LivDerm


 

Update on Biologic Therapies in Dermatology: Understanding the IL-17 and IL-23 Pathways/Efficacy of Novel Targeted Pharmaceuticals for Atopic Dermatitis and Psoriasis

By LivDerm FEATURING David E. Cohen
February 18, 2021

0 Comments
Login to view comments. Click here to Login